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Abstract: Rats were exposed to nickel oxide nanoparticles (NiO-NP) inhalation at 0.23 ± 0.01 mg/m3
for 4 h a day 5 times a week for up to 10 months. The rat organism responded to this impact with
changes in cytological and some biochemical characteristics of the bronchoalveolar lavage fluid
along with a paradoxically little pronounced pulmonary pathology associated with a rather low
chronic retention of nanoparticles in the lungs. There were various manifestations of systemic toxicity,
including damage to the liver and kidneys; a likely allergic syndrome as indicated by some cytological
signs; transient stimulation of erythropoiesis; and penetration of nickel into the brain from the nasal
mucous membrane along the olfactory pathway. Against a picture of mild to moderate chronic toxicity
of nickel, its in vivo genotoxic effect assessed by the degree of DNA fragmentation in nucleated blood
cells (the RAPD test) was pronounced, tending to increasing with the length of the exposure period.
When rats were given orally, in parallel with the toxic exposure, a set of innocuous substances with
differing mechanisms of expected bioprotective action, the genotoxic effect of NiO-NPs was found to
be substantially attenuated.
Keywords: nickel oxide nanoparticles; inhalation exposure; pulmonary responses; systemic toxicity;
genotoxicity; bioprotectors
1. Introduction
Like many other metal-oxide nanoparticles species that we toxicologically characterized in
experiments during 2009–2017 and reported in research papers and overviews [1,2], nickel-oxide
nanoparticles (NiO-NPs) are of special interest for industrial toxicology and occupational health risk
assessment and management. Not only are engineered NiO-NPs produced for various industrial
applications (such as photoelectric and recording materials, catalysts, sensors, and ceramics), but they
also make up a substantial proportion in the particle size distribution of condensation aerosols
generated by traditional metallurgical and arc-welding technologies. While comprising chemically
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similar fine micrometer and submicron-sized (>100 nm) particles, such aerosols commonly contain the
conventional nanoscale fraction (<100 nm) as well [1].
It is no wonder that NiO-NP toxicology has been, and still is, the subject-matter of numerous
experimental studies. However, the prevailing majority of the relevant studies were done in vitro on
cultured cells (e.g., [3–7]) or sometimes in vivo on daphnia [8] and drosophila [9], while the experiments
on laboratory rodents used mostly single-shot or repeated intratracheal instillations [7,10–16] and,
occasionally, oral administration [17].
We have not come across any studies that would examine the chronic toxicity of NiO-NPs by
a reasonably large number of informative indicators using a long-term inhalation exposure. In the
studies we know of, such exposure lasted no longer than 4 weeks [18–21].
In summary, the above-mentioned and similar publications have demonstrated pronounced toxicity
of NiO-NPs on cell, organ, and system (mainly respiratory) levels and moderate in vivo genotoxicity.
They have also shown that one of the primary mechanisms of action on the cell is the generation of
free oxygen radicals. All of these phenomena are, to a greater or lesser degree, characteristic of any
metal and metal-oxide nanoparticles (MeO-NPs) studied so far. However, toxicologists still lack enough
quantitative or even descriptive data to support a reliable assessment of health risks associated with
occupational and environmental exposures to NiO-NPs.
In particular, although Ni as a chemical element is a recognized human carcinogen due to its
genotoxicity and although the genotoxic effects of NiO-NPs have been demonstrated not only on cell
lines or on drosophila [9] but also in some acute (for instance, [16]) or even subchronic [22] experiments
on rats, no such data seem to be available from chronic inhalation studies, nor is there any reliable
assessment of pulmonary and systemic non-genotoxic adverse effects. One therefore cannot be certain
that it is the genotoxicity of NiO-NPs in actual industrial and residential conditions that is to be
regarded as an adverse characteristic of top priority.
Last but not least, virtually nobody outside our team in nano-toxicological research has ever tried
to raise the problem of enhancing the organism’s resistance to the systemic toxic action and genotoxicity
of the MeO-NP species under consideration or of any other such NPs. Although we developed [22] a
combination of bioprotectors and successfully tested it against combined nickel-manganese NiO-NP +
Mn3O4-NP intoxications [23], it was still unknown whether such a combination was effective against
the toxicity of NiO-NPs proper. Moreover, despite our wide experience in bioprotection against acute
and subchronic effects of various metals in the form of ions or nanoparticles [22,24], we have not yet
performed such studies for chronic inhalation nano-intoxications.
2. Results and Discussion
2.1. A Pilot Experiment
As was emphasized in the introduction, the experimental data on the inhalation toxicity of
NiO-NPs reported so far have been obtained [18–21] for exposures that were not long-term and in
this respect not comparable, even for the short lifespan of rats, with possible occupational exposure
durations that are of primary interest in the area of preventive industrial toxicology. Indeed, if we
assume that the average lifespan of a laboratory rat is equal to 30 months, inhalation experiments that
last 4 weeks (i.e., only about 3% of the total lifespan) are negligibly short in comparison with a human
working lifetime (which, e.g., in Russia amounts, even under hazardous occupational conditions,
to ~50% of the standard human lifetime). Moreover, a tolerable single four-hour exposure of rats
in “nose only” inhalation setups is much shorter than the working day, even if it is reduced under
hazardous conditions. This circumstance further shortens the total chronic exposure in experiments
compared with actual occupational contexts.
For these reasons, we designed a chronic inhalation experiment intended to last 3–10 months and
involving an average concentration of 1.0 mg/m3 of NiO-NPs in the air inhaled by rats. This exposure
concentration was considered to be moderate and to allow for the position of regulatory toxicology in
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relation to metallic nickel and its water-insoluble compounds in workroom air (for example, the US
OSHA established a PEL equal just to 1.0 mg/m3 as a TWA concentration). Assuming that any
chemical compound of nickel is likely to be more toxic compared with its iron-containing counterpart,
we expected that, for nano-sized nickel-oxide particles, this concentration would be even more
toxicologically effective (rather than being innocuous) than for Fe2O3 iron oxide nanoparticles in
about the same concentration (1.14 ± 0.01 mg/m3) tested by us previously in a similar inhalation
experiment [25]. At the same time, we assumed that the contrary role as a factor that determines the
comparative toxicity of these two metal-oxide nanoparticle species would be the nearly twice as great
diameter of NiO-NPs (23 ± 5 nm) in comparison to Fe2O3-NPs (14 ± 4 nm).
Nevertheless, the expectation of a substantial toxicity of nickel-oxide nanoparticles in this
concentration unexpectedly came not only true but was even exceeded so much that already after
the first 1–2 exposures the clinical picture of an acute intoxication became evident. We were afraid,
therefore, that the animals would not live long enough for a chronic intoxication to develop in them.
We thus decided to interrupt the experiment after only five daily exposures and to begin a new one
with the average concentration of NiO-NPs lowered 4–5 times (see Section 3).
However, we have measured in these rats at least some of the indices that were planned by the design
of the chronic experiment (see Section 3) in order to use them as predictors of the results in the longer-term
experiment. Therefore, we regard the first inhalation experiment as a pilot rather than a failure.
As follows from Table 1 (which presents mostly those indices for which the exposed group differed
from the controls statistically significantly), even though the total exposure period was short, certain
functional effects of toxic action did manifest themselves. We noted the following:
- an increase in liver mass typical of subchronic and chronic intoxications with practically all
metal-oxide nanoparticles ever studied by us;
- elevated release of lactate dehydrogenase in the blood due, probably, to the toxic damage to the
liver cells and to the pulmonary macrophages;
- leukocytosis;
- systemic inhibition of the oxidation-reduction energy metabolism, the integrated cytochemical
indicator of which is the suppression of succinate dehydrogenase activity in blood lymphocytes,
which we repeatedly observed in experiments involving practically any of the toxic metals in any
form [23,26–28];
- enhanced lipid peroxidation judging by the increased concentration of malondialdehyde in
the blood;
- stimulation of erythropoiesis suggested by an increase in the erythrocyte count (along with an
increased proportion of reticulocytes), hematocrit, and hemoglobin content of the blood.
Such a quasi-beneficial hematological effect is astonishing not only because various metal-induced
intoxications go along with this or because of the degree of anemia with different mechanisms of
development but also because intraperitoneal subchronic intoxication caused by similar NiO-NPs was
previously found by us [23] to bring about just such anemia. We will consider this apparent contradiction
below (Section 2.2) when discussing the findings of the main chronic inhalation experiment, in which
such stimulation was again observed. As for the pilot experiment being considered, it is noteworthy
that even one week after its termination the red blood still displayed a response, although it was
less pronounced. For instance, the proportion of reticulocytes was equal to 25.86 ± 3.88% against
15.22 ± 1.37% in the control group (p < 0.05).
In 24 h after the last exposure, a dramatic increase in both the bronchoalveolar lavage fluid (BALF)
total cell count and the number of alveolar macrophages (AMs) and neutrophil leukocytes (NLs) in
comparison with the corresponding indices in the control group was observed (Table 2). The NL/AM
ratio was, however, somewhat decreased, which is not characteristic of the immediate pulmonary
response to the deposition of any particles and, in particular, of highly cytotoxic ones [1,23,26–32].
Three weeks later, the differences between the NiO-NP-exposed and control groups in the BALF total
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cell count and the AM numbers remained statistically significant although somewhat decreased, while
the initial neutrophilic response disappeared.
Table 1. Some indices of rat organism status after a short-term inhalation exposure to NiO nanoparticles
at a concentration of 1.0 ± 0.1 mg/m3—4 h exposure for 5 consecutive days (x ± s.e.).
Index
24 h after the Fifth Exposure
Control NiO-NP
Body mass before exposure, g 250.0 ± 4.8 242.8 ± 3.3
Body mass after exposure, g 255.63 ± 3.71 247.50 ± 3.56
Body mass gain, % 13.5 ± 5.6 11.4 ± 2.7
Liver mass, g per 100 g body mass 3.12 ± 0.05 3.41 ± 0.07 *
Leukocytes, 106/mL 8.68 ± 0.62 10.94 ± 0.64 *
Erythrocytes, 1012/mL 6.92 ± 0.13 7.33 ± 0.14 *
Reticulocytes, % 19.01 ± 1.58 46.43 ± 3.14 *
Hemoglobin, g/dL 14.60 ± 0.23 15.44 ± 0.21 *
Hematocrit, % 41.32 ± 0.62 43.32 ± 0.62 *
LDH, U/L 1665.13 ± 273.57 2663.00 ± 360.17 *
MDA in blood serum, µmol/L 5.72 ± 0.37 8.140 ± 1.09 *
SDH activity, number of formazan granules in 50 lymphocytes 800.25 ± 36.65 553.88 ± 10.10 *
Note: * statistically significant difference from the sham-exposed group (p < 0.05 by a Student’s t-test).
Table 2. Number of cells in the bronchoalveolar lavage fluid (BALF) after 4 h inhalation exposures to
NiO-NPs at a 1.0 ± 0.1 mg/m3 concentration repeated daily for 5 days (x ± s.e.).
Number of Cells (× 106)
Group of Rats
Exposed to Total
Neutrophil
Leukocytes (NLs)
Alveolar
Macrophages (AMs) NL/AM
24 h after the Last Exposure
NiO-NP 6.39 ± 0.68 * 1.37 ± 0.19 5.02 ± 0.61 * 0.29 ± 0.05
Sham 1.72 ± 0.34 0.66 ± 0.32 1.06 ± 0.15 0.67 ± 0.39
21 Days after the Last Exposure
NiO-NP 3.25 ± 0.24 * 0.33 ± 0.07 2.92 ± 0.27 * 0.12 ± 0.03
Sham 1.86 ± 0.13 0.37 ± 0.17 1.50 ± 0.14 0.29 ± 0.14
Note: * statistically significant difference from the sham-exposed group ((p < 0.05 by a Student’s t-test).
Recently we published (for the first time in nanotoxicology, as far as we know) a cytological analysis
of tissue imprints from organs of rats exposed subchronically to intraperitoneally injected metal-oxide
nanoparticles in experiments with Al2O3-NPs, TiO2-NPs, and SiO2-NPs administered separately or
in different combinations [27]. That analysis proved to be rather informative. Simultaneously we
explored the potentialities of this approach in the pilot inhalation experiment under discussion now
and obtained some interesting results (Table 3).
In particular, the following findings are noteworthy:
- the lungs had increased proportions of explicitly degenerated alveolar macrophages and
of eosinophils;
- the liver had increased proportions of explicitly degenerated hepatocytes, activated Kupffer’s cells,
neutrophils, and eosinophils;
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- the kidneys had increased proportions of explicitly degenerated cells of proximal (and to a much
lesser degree, distal) convoluted tubules;
- the spleen displayed a decrease in the proportion of mature lymphocytes together with
prolymphocytes and a respective increase in the proportion of other white cells, especially eosinophils.
Thus, notwithstanding rather a short inhalation period and a seemingly low exposure level, we can
see some typical adverse effects on target organs along with hyperergic toxic inflammation evidenced
by a marked eosinophilic response. It would be an enticing hypothesis to connect the latter with
the well-known systemic nickel allergy syndrome if a similar response had not been observed in
the above-mentioned experiments with three other NPs of elements, none of which is, unlike nickel,
a recognized potent sensitizer [27]. In this respect, we should mention the urgency of the well-recognized
general problem of “nanoparticles and allergy” [33], which has not yet been solved satisfactorily.
Table 3. Some cytological characteristics of different organ imprints from rats sacrificed on the next day
after the fifth 4 h inhalation exposure to NiO-NPs at a 1.0 ± 0.1 mg/m3 concentration; percentage of
total cell count (x ± s.e.).
Organs and Cells In Sham-Exposed Rats (Control) In NiO-HP-Exposed Rats
Lungs
Neutrophils 8.00 ± 0.81 10.29 ± 0.87
Alveolar macrophages 6.25 ± 0.89 6.86 ± 1.30 *
Degeneratively changed alveolar
macrophages 6.25 ± 0.81 28.71 ± 3.34 *
Eosinophils 1.75 ± 0.49 10.00 ± 1.31 *
Liver
Degeneratively changed
hepatocytes 8.75 ± 0.84 21.86 ± 0.99 *
Neutrophils 7.25 ± 0.66 11.57 ± 0.97 *
Eosinophils 3.50 ± 0.40 7.29 ± 0.68 *
Kupffer cells 3.00 ± 0.68 5.43 ± 0.48 *
Kidneys
Proximal tubule cells 67.75 ± 0.85 51.00 ± 1.60 *
Degeneratively changed cells of
proximal tubules 11.33 ± 0.58 22.71 ± 1.64 *
Distal tubule cells 7.67 ± 0.85 10.00 ± 0.72
Degeneratively changed cells of
distal tubules 5.67 ± 0.65 8.43 ± 0.65 *
Spleen
Mature lymphocytes,
prolymphocytes 85.60 ± 2.29 72.57 ± 1.73 *
Lymphoblasts 0.80 ± 0.20 1.29 ± 0.29
Plasmocytes 1.40 ± 0.24 3.00 ± 0.53 *
Macrophages 2.40 ± 0.24 3.14 ± 0.34
Neutrophils 2.40 ± 0.51 4.43 ± 0.37 *
Eosinophils 4.60 ± 0.68 13.71 ± 0.97 *
Note: * statistically significant difference from the sham-exposed group ((p < 0.05 by a Student’s t-test).
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2.2. A Long-Term Low Level Exposure
As will be described in detail in Section 3, in this experiment, the NiO-NP concentrations
were approximately four times lower compared with the pilot one (0.23 ± 0.01 mg/m3 instead of
1.0 ± 0.1 mg/m3). In other respects the mode and duration of weekly exposures were the same (4 h a
day, 5 times a week), but the total exposure period was prolonged up to 3, 6, or 10 months.
As follows from the comparison of the data presented in Tables 2 and 4, the shifts in the cytological
characteristics of the BALF 24 h after the final inhalation exposure to nanoparticles in the chronic
inhalation experiment were, unlike the pilot one, of the usual character (an increase in total cell count
due to the recruitment of both AMs and NLs with an increased NL/AM ratio in comparison with the
control group). Believing that such shifts were determined mainly by the response to the last portions
of particles deposited in the lower airways, we did not expect them to increase by increasing the overall
duration of the exposure period. Indeed, the cytological characteristic of the BALF after the 6-month
and 10-month exposure was in principle the same. However, over both of these experimental periods,
the total cell counts and the AM and NL numbers were much lower than after the 3-month exposure.
Table 4. Number of cells in the BALF obtained 24 h after the last 4 h inhalation exposure to the NiO-NPs
at a 0.23 ± 0.01 mg/m3 concentration repeated daily for 3, 6, or 10 months; mean results for at least
12 rats in exposed and sham-exposed groups of each term (x ± s.e.).
Number of Cells (× 106)
Group of Rats
Exposed to: Total
Neutrophil
Leukocytes (NL)
Alveolar
Macrophages (AM) NL/AM
3 months
NiO-NP 21.40 ± 6.01 * 8.40 ± 3.11 * 13.00 ± 3.22 * 0.61 ± 0.11
Sham 3.50 ± 0.66 0.43 ± 0.18 3.06 ± 0.69 0.26 ± 0.18
6 months
NiO-NP 8.38 ± 0.81 * 1.72 ± 0.26 * 6.67 ± 0.66 * 0.26 ± 0.04 *
Sham 2.94 ± 0.53 0.27 ± 0.08 2.78 ± 0.53 0.11 ± 0.04
10 months
NiO-NP 9.63 ± 1.15 * 3.74 ± 0.78 * 5.89 ± 0.70 * 0.65 ± 0.12 *
Sham 3.44 ± 0.46 0.30 ± 0.08 3.14 ± 0.39 0.09 ± 0.02
Note: * statistically significant difference from the sham-exposed group (p < 0.05 by a Student’s t-test).
Our studies demonstrated long ago that the intensity of the protective compensatory recruitment
of alveolar macrophages and, particularly, neutrophil leukocytes into the lower airways is higher as the
particles become more cytotoxic and thus as the mass of produced macrophage breakdown products
(MBPs) regulating this recruitment increases [29,34]. However, the recruitment of new echelons of
phagocytizing cells in response to an intratracheal instillation of one and the same dose of sterile
MBPs (obtained by freezing-thawing or ultrasonication of a macrophage culture in aseptic conditions)
greatly depends on the total reactivity of the organism, which may change under the effect of various
factors [31]. Assumingly, in the current experiment, a similar change in the reactivity of the organism
took place. This change might be, on the one hand, a result of the chronic intoxication suppressing this
reactivity and, on the other hand, a manifestation of the organism’s partial adaptation to the impact of
inhaled particles.
At the same time, the increased activity of the BALF supernatant’s enzymes (Table 5) is likely to
reflect the destruction of cells on the free surface of the lungs’ pulmonary region under the impact
of cytotoxic particles. Since the exposure to NiO-NPs was constant, it is not surprising that these
biochemical indices were relatively stable in all three experimental periods.
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Table 5. Some enzymes in the BALF supernatant obtained 24 h after the last 4 h inhalation exposure to
NiO-NPs at a 0.23 ± 0.01 mg/m3 concentration repeated daily for 3, 6, or 10 months; mean results for at
least 12 rats in exposed and sham-exposed groups of each term (x ± s.e.).
Group of Rats
Exposed to:
γ-Gutamyl
Transferase Amylase
Lactate
Dehydrogenase
Alkaline
Phosphatase
Aspartate
Aminotransferase
3 Months
NiO-NP 21.76 ± 2.52 * 16.64 ± 2.65 * 218.33 ± 31.9 * 69.61 ± 21.03 23.84 ± 3.61 *
Sham 1.04 ± 0.34 2.94 ± 0.41 14.3 ± 2.9 28.49 ± 7.22 4.83 ± 0.42
6 Months
NiO-NP 16.56 ± 1.34 * 15.72 ± 2.44 * 360.3 ± 54.6 * 99.48± 18.36 * 37.83± 6.12 *
Sham 3.96 ± 1.48 5.11 ± 1.35 16.3 ± 1.1 37.47 ± 6.63 9.39 ± 3.43
10 Months
NiO-NP 13.61 ± 2.87 * 9.66 ± 2.49 * 256.00 ± 5.7 * 67.74 ± 21.78 * 37.83± 6.12 *
Sham 2.17 ± 0.71 2.03 ± 0.45 19.00 ± 5.7 16.73 ± 5.46 9.39 ± 3.43
Note: * statistically significant difference from the sham-exposed group (p < 0.05 by a Student’s t-test).
In Table 6 we present all functional indices for the organism’s status measured in both exposed
and control (sham-exposed) rats to find whether any of them revealed statistically significant and/or
consistent shifts that might be attributed to the NiO-NP toxic action.
In fact, like the above-discussed cytological BALF indices, the systemic toxic action effects of
inhaled nanoparticles presented in this table suggest that the rat organism was gradually adapting to
some extent to the low-level inhalation exposure. In this respect, of particular interest are the red blood
indices. Previously we found [23] that under a subchronic intraperitoneal exposure to the NiO-NPs
they generally developed anemia. At the same time, under low-level inhalation burdens we can see
signs of erythropoiesis stimulation both in the short-term pilot experiment (see Section 2.1) and by
the end of the 3rd month in the main experiment. In the latter case, these signs included an elevated
hemoglobin content, an increased erythrocyte count with an elevated proportion of reticulocytes,
and an elevated hematocrit. However, in the subsequent terms of this investigation, the possible
reaction of the marrow bone was evidenced only by a statistically significant increase in the proportion
of reticulocytes.
The effect produced by various chemical forms of nickel on erythropoiesis is not something
new, although we have not come across any references to such nanoparticle action in this metal.
Thus, Sunderman et al. [35] observed an enhanced generation of erythropoietin with an increase in
hematocrit in guinea pigs and rats in response to intrarenal administration of nickel subsulfide. On the
contrary, anemia is known to develop in rats under intoxication, for example, with nickel chloride [36].
Phase-related changes in the red blood indices under a 4-month (every other day) inhalation exposure
to micrometer particles of metallic nickel or nickel oxide at a concentration of 350 mg/m3 were described
a long time ago [37]. An enhancement of erythropoiesis was noted in 2 weeks, lasted for 1.5 months,
and then decreased to the initial level or fell below it. Later on, a study involving continuous 3-month
inhalation exposure to a rather coarse metallic nickel dust at a concentration of 0.5, 0.1, and 0.02 mg/m3
also revealed an increase in the erythrocyte count in the peripheral blood after 2.5 months of exposure
followed by normalization of this index by the end of the exposure period [38].
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Table 6. Some functional indices for rat organism status 24 h after the last 4 h inhalation exposure to NiO-NPs at a 0.23 ± 0.01 mg/m3 concentration repeated daily for
3, 6, or 10 months; mean results for at least 12 rats in exposed and sham-exposed groups of each term (x ± s.e.).
Indices
3 Months 6 Months 10 Months
Control NiO-NP Control NiO-NP Control NiO-NP
Starting body mass, g 241.2 ± 9.2 230.1 ± 4.9 249.1 ± 42 248.5 ± 5.1 232.9 ± 4.1 230.6 ± 3.6
Final body mass, g 275.4 ± 8.5 262.5 ± 4.8 282.9 ± 6.0 290.3 ± 4.9 287.9 ± 4.3 275.3 ± 7.6
Body mass gain, % 15.2 ± 3.9 14.4 ± 2.3 13.7 ± 2.3 17.4 ± 2.7 25.1 ± 2.8 17.2 ± 1.7 *
Lung mass (dry), g per 100 g body mass 0.15 ± 0.03 0.17 ± 0.01 0.12 ± 0.02 0.15 ± 0.03 0.11 ± 0.01 0.20 ± 0.02 *
Liver mass (wet), g per 100 g body mass 3.24 ± 0.14 3.52 ± 0.13 0.301 ± 0.037 0.250 ± 0.040 * 3.44 ± 0.10 3.41 ± 0.09
Spleen mass (wet), g per 100 g body mass 0.21 ± 0.01 0.22 ± 0.02 0.30 ± 0.06 0.24 ± 0.01 0.21 ± 0.01 0.25 ± 0.02
Kidney mass (wet), g per 100 g body mass 0.63 ± 0.02 0.64 ± 0.02 0.65 ± 0.02 0.69 ± 0.02 0.62 ± 0.02 0.67 ± 0.02 *
Brain mass (wet), g per 100 g body mass 0.70 ± 0.04 0.75 ± 0.02 0.72 ± 0.02 0.71 ± 0.02 0.69 ± 0.02 0.73 ± 0.02
Temporal summation of sub-threshold impulses, sec. 11.02 ± 0.74 10.53 ± 0.47 12.67 ± 0.94 11.31 ± 0.68 11.39 ± 0.82 10.87 ± 0.74
Number of head-dips into holes during 3 min 5.83 ± 1.09 5.58 ± 1.11 6.19 ± 0.84 5.88 ± 0.93 7.00 ± 1.21 8.83 ± 1.13
Number of crossed squares per 3 min 14.25 ± 1.71 12.67 ± 1.54 18.56 ± 2.19 17.31 ± 2.56 12.55 ± 1.54 16.16 ± 1.95
Hemoglobin, g/dL 14.13 ± 0.35 15.82 ± 0.28 * 15.28 ± 0.18 15.11 ± 0.21 15.15 ± 0.38 15.47 ± 0.22
Erythrocytes, 1012 cells/L 6.37 ± 0.22 7.08 ± 0.17 * 7.23 ± 0.11 6.94 ± 0.12 6.92 ± 0.24 6.75 ± 0.08
Average volume of red blood cells, µm3 58.23 ± 0.65 58.83 ± 0.58 59.90 ± 0.57 62.24 ± 0.57 * 57.85 ± 0.90 59.05 ± 0.44
Hematocrit, % 37.18 ± 1.16 41.56 ± 0.86 * 43.28 ± 0.58 43.18 ± 0.66 39.94 ± 1.22 39.22 ± 0.84
Reticulocytes, % 11.92 ± 1.28 16.75 ± 1.39 * 13.73 ± 1.28 20.39 ± 1.56 * 12.55 ± 0.86 15.89 ± 0.62 *
Leukocytes, 103/µL 6.93 ± 0.61 6.00 ± 0.45 5.79 ± 0.42 5.68 ± 0.33 5.62 ± 0.27 6.36 ± 0.38 *
Thrombocytes, 103/µL 0.22 ± 0.02 0.25 ± 0.01 0.26 ± 0.01 0.24 ± 0.01 0.19 ± 0.02 0.22 ± 0.01
Lymphocytes, % 66.67 ± 1.27 69.11 ± 1.05 63.19 ± 1.20 61.20 ± 1.10 53.19 ± 3.78 57.22 ± 0.89
Monocytes, % 6.00 ± 0.41 5.22 ± 0.36 4.69 ± 0.33 4.07 ± 0.34 5.81 ± 0.44 7.67 ± 1.51
Granulocytes, %
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Table 6. Cont.
Indices
3 Months 6 Months 10 Months
Control NiO-NP Control NiO-NP Control NiO-NP
Bilirubin in blood serum, µmol/L 1.09 ± 0.17 1.56 ± 0.14 * 0.96 ± 0.14 1.30 ± 0.09 * 1.14 ± 0.10 1.66 ± 0.23 *
Succinate dehydrogenase (SDH) activity, number of
formazan granules per 50 lymphocytes 747.3 ± 9.2 553.3 ± 5.8 * 621.6 ± 10.7 640.7 ± 10.8 619.3 ± 11.1 619.4 ± 6.8
Total protein content of blood serum, g/L 69.37 ± 2.16 69.90 ± 1.65 68.71 ± 1.73 70.43 ± 1.90 72.82 ± 2.37 72.69 ± 2.24
Albumin content of blood serum, g/L 40.78 ± 2.22 39.53 ± 1.16 40.34 ± 1.05 40.50 ± 091 39.63 ± 1.26 39.04 ± 1.52
Globulins of blood serum, g/L 28.59 ± 1.58 30.0 ± 1.04 28.94 ± 1.35 29.92 ± 1.32 33.19 ± 1.41 30.11 ± 2.65
A/G index 1.56 ± 0.24 1.36 ± 0.07 1.43 ± 0.07 1.38 ± 0.05 1.21 ± 0.04 1.17 ± 0.04
AST activity in blood serum, mM/h·L 911.08 ± 616.72 289.88 ± 30.71 193.85 ± 17.24 198.86 ± 11.46 304.02 ± 48.40 279.96 ± 16.65
ALT activity in blood serum, mM/h·L 337.38± 278.35 70.08 ± 10.56 67.01 ± 6.51 61.69 ± 3.52 57.37 ± 4.48 54.42 ± 4.88
De Ritis coefficient 4.89 ± 0.46 4.52 ± 0.32 2.97 ± 0.17 3.34 ± 0.22 5.12 ± 0.39 5.43 ± 0.28
SH-groups in blood serum, µmol/L 10.19 ± 0.53 10.82 ± 0.68 6.67 ± 0.26 6.07 ± 0.95 3.52 ± 0.68 4.31 ± 0.58
Uric acid in blood serum, µmol/L 100.50 ± 7.52 103.7 ± 6.42 102.63 ± 7.66 97.50 ± 7.59 172.75 ± 24.13 146.94 ± 8.33
Urea in blood serum, mmol/L 6.20 ± 2.14 5.04 ± 2.43 2.77 ± 0.15 2.79 ± 0.34 5.52 ± 0.93 4.42 ± 0.46
Activity of γ-glutamintransferase in blood serum,
nmol/(s·L) 3.7 ± 1.21 2.87 ± 0.81 2.66 ± 0.80 2.58 ± 1.04 9.89 ± 1.80 9.17 ± 1.37
Creatinine in blood serum, µmol/L 56.43 ± 5.87 48.14 ± 3.26 46.42 ± 2.02 52.61 ± 2.19 * 57.95 ± 3.57 57.54 ± 2.99
Alkaline phosphatase in blood serum, nmol/(s·L) 51.58 ± 6.34 58.58 ± 4.61 135.03 ± 10.63 114.80 ± 13.60 113.63 ± 11.08 90.08 ± 15.05
Catalase in blood serum, µmol/L 0.15 ± 0.03 0.11 ± 0.02 0.54 ± 0.03 0.56 ± 0.03 0.55 ± 0.06 0.60 ± 0.02
Reduced glutathione in the blood hemolysate, µmol/L 31.15 ± 3.63 24.40 ± 3.83 18.36 ± 1.80 18.67 ± 3.96 24.91 ± 1.73 21.12 ± 0.85
Ceruloplasmin in blood serum, mg/% 133.11 ± 12.04 116.83 ± 15.13 67.40 ± 3.70 87.35 ± 10.07 96.49 ± 8.96 120.67 ± 9.22
MDA in blood serum, nmol/L 5.17 ± 0.39 3.97 ± 0.31 * 5.07 ± 0.38 5.74 ± 0.61 5.56 ± 0.72 7.84 ± 0.79 *
Diuresis, mL 31.08 ± 4.72 39.00 ± 2.58 30.58 ± 2.70 26.83 ± 4.54 38.42 ± 3.16 42.19 ± 3.19
Urine relative density 1.01 ± 0.0 1.02 ± 0.0 1.01 ± 0.0 1.02 ± 0.0 1.019 ± 0.0 1.017 ± 0.0
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Table 6. Cont.
Indices
3 Months 6 Months 10 Months
Control NiO-NP Control NiO-NP Control NiO-NP
Protein in urine, g/L 144.1 ± 12.9 137.7 ± 7.4 69.8 ± 8.25 108.5 ± 15.94 * 96.4 ± 32.85 181.8 ± 122.39
Urea in urine, mmol/L 95.2 ± 7.8 106.6 ± 14.3 240.3 ± 25.2 235.2 ± 34.7 175.6 ± 9.3 111.2 ± 8.1 *
Uric acid in urine, µmol/L 52.00 ± 11.13 79.73 ± 14.01 181.09 ± 26.8 178.36 ± 29.5 83.25 ± 9.9 57.50 ± 8.1
Creatinine in urine, mmol/L 1.19 ± 0.12 1.01 ± 0.06 1.73 ± 0.12 1.63 ± 0.16 1.27 ± 0.07 1.10 ± 0.09
Endogenous creatinine clearance, ml/min 0.66 ± 3.27 0.82 ± 2.42 1.14 ± 2.2 0.83 ± 2.62 0.84 ± 2.6 0.8 ± 2.51
Genomic DNA fragmentation coefficient in nucleated
blood cells 0.4229 ± 0.0008 0.4480 ± 0.0017 * 0.4247 ± 0.0006 0.5332 ± 0.0031 * 0.4244 ± 0.0005 0.5447 ± 0.0036 *
Note: * statistically significant difference from the sham-exposed group (p < 0.05 by a Student’s t-test with Bonferroni correction).
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It is interesting that we found a similar alternating pattern of response to chronic inhalation of
NiO-NPs for such an important toxic effect as energy metabolism suppression as well. Indeed, the typical
decrease in the cytochemical index of SDH activity in blood lymphocytes was pronounced and statistically
significant by the end of the 3rd month but was absent in the next month. On the contrary, the intensity
of lipid peroxidation estimated by the concentration of malondialdehyde (MDA) in the blood serum
increased significantly only towards the end of the long-term exposure period. Meantime, it was
significantly reduced in the first term (which is an extremely rare and hard-to-explain effect) and virtually
unchanged in the mid-term. No significant changes in reduced glutathione and total SH-groups in the
blood-typical effects for different metal intoxications—were observed in this instance.
What is particularly noticeable is the insignificance and inconstancy of many other (including
organ-specific) shifts caused by low-level chronic inhalation exposure to NiO-NPs. Thus, none of
the usually observed signs of increased inhibition processes in the CNS (longer index of summation
of subthreshold impulses, suppression of the behavioral indices of exploratory, and general motor
activities) displayed, in the chronic inhalation experiment, any statistically significant difference from
the control value. Rather, they generally tended to be oppositely directed, especially at the end of the
exposure period. This circumstance is particularly interesting because under inhalation exposure one
of the targets for nanoparticles initially deposited in the nasal ways is the brain, to which they move
along the fibers of the olfactory nerve [25,39–41]. Indeed, the electron microscopy of olfactory bulb
preparations from the rat brain in this experiment revealed both nanoparticle retention (Figure 1) and
ultrastructural damage (Figures 2 and 3). The averaged nickel content of the homogenized tissues
of the entire brain was just slightly increased, which indirectly confirms the local nature of NiO-NP
retention limited to the olfactory tract.Int. J. Mol. Sci. 2018, 19, x 2 of 25 
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There was no noticeable change in the relative mass of the liver, spleen, and kidneys or in
indices of liver functioning (the protein and separate protein fractions content in the blood serum
and aminotransferase activities) or of kidney functioning (diuresis, urine density, and endogenous
creatinine clearance). At the same time, in all three periods of this inhalation exposure, increased
bilirubin content in the blood serum and proteinuria after 6 and 10 months of exposure (statistically
significant only by the 6th month) was observed.
The low manifestation of the hepato- and nephrotoxicity effects may be explained by the fact
that the nickel content of these organs, both total (by the AES data) and as NiO (by EPR-spectroscopy
data), virtually did not differ from the control values. Thus, by the end of the 10-month period,
for the liver it was equal in the control group to 0.65 ± 0.22 and 0.06 ± 0.02 µg per gram of dry tissue,
respectively, while in the exposed group it was equal to 0.73 ± 0.17 and 0.07 ± 0.03 µg/g; for kidneys,
it was equal to 0.31 ± 0.08 and 0.03 ± 0.01 µg/g in the control group and 0.35 ± 0.06 and 0.02 ± 0.01 µg/g
in the exposed group. No additional accumulation of nickel in the spleen of the exposed rats was
observed: 0.25 ± 0.07 µg/g by the AES data and 0.01 ± 0.01 µg/g by the EPR data (against 0.27 ± 0.03
and 0.02 ± 0.00 µg/g in the control group). Meanwhile, both indices of blood nickel content in the
exposed rats (0.48 ± 0.05 and 0.53 ± 0.14 µg/g) were higher than the corresponding control values
(0.39 ± 0.07 and 0.30 ± 0.07 µg/g), but not by much, and the increase was statistically insignificant.
Int. J. Mol. Sci. 2019, 20, 1778 13 of 24
A low chronic accumulation of NiO-NPs in the above-mentioned organs as well as in the lungs
(see below) is presumably due mostly to its solubilization in biological milieus, which could be directly
proved in vitro (Figure 4).
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It is worth mentioning that in the case of inhalation exposure there is an increase in dry mass 
of lungs, a typical observation for any experimental pneumoconiosis. In this case, however, this 
increase grew statistically significant only by the 10th month. By this time, the retention of nickel in 
the lung tissue was the highest according to both the AES data (3.69 ± 0.35 against 0.96 ± 0.30 μg/kg 
in the sham-exposed group; p < 0.05) and the EPR spectroscopy (0.39 ± 0.04 and 0.09 ± 0.03 μg/kg, 
respectively; p < 0.05). Nevertheless, electron microscopy of the lungs (Figure 5) revealed numerous 
nanoparticles or their nano-sized aggregates in all periods of the study not only as internalized by 
phagocytic cells but also as located freely inside alveoli, which seems to be a result of their recent 
deposition from the inhaled air.  
Figure 4. Decay kinetics of the Ni2+ EPR signal from a filter on which NiO-NPs deposited from the
inhalation exposure chamber exhaust air (a) i de-i nized water, (b) in rat BALF supernatant, and (c) in
steri e b vine blood seru .
It is worth mentioning that in the case of inhalation exposure there is an increase in dry mass
of lung , a typical observation for any experiment l p eum coniosis. In this case, however, thi
increase grew statistically significant only by the 10th month. By this time, t e retention of nickel in
the lung tissue was the highest a cordi g to both the AES data (3.69 ± 0.35 against 0.96 ± 0.30 µg/kg
in the sham-exposed group; p < 0.05) and the EPR spectroscopy (0.39 ± 0.04 d 0.09 ± .03 µ / ,
respectively; p < 0.05). Nevertheless, electron micro copy f the lungs (Figure 5) revealed numerous
nanoparticles or their nano-siz d aggr gates in all periods of the study not only as inter aliz d by
phagocyti cells but also as located freely inside alv oli, whic seems to be a result of their recent
deposition from the inhaled air.Int. J. Mol. Sci. 2018, 19, x 4 of 25
 
 
Figure 5. Rat lungs after 3 months of inhalation exposure to NiO-NPs at a concentration of 0.23 
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Figure 6. Rat lungs (a) after 10-month inhalation exposure to NiO-NPs and (b) in the control group 
of the same exposure period. Gomori’s silver impregnation, magnification: 400×. See description in 
the text. 
At the same time, a histological investigation of the lung tissue by optical microscopy did not 
reveal, even towards the end of the experiment, any cellular fibrotic nodules typical of experimental 
pneumoconioses, or any thickening of interalveolar septae together with their diffuse fibrosis. On 
the contrary, the septae became thinner or were even destroyed (emphysema), while the reticulin 
framework was no coarser than in the control rats (Figure 6). 
Besides the above-considered functional indices, all internal organs displayed appreciable, 
even if moderate, pathological changes in the histological structure confirmed by optical 
microscopy-based morphometric assessment (Table 7; Table 8). The fact that there was no increase 
in the proportion of akaryotic hepatocytes after the 3-month exposure is quite consistent with the 
observation that in this period the retention of nickel in the liver was still negligibly low (according 
to AES data, 0.10 ± 0.05 against 0.08 ± 0.03 mg/kg in the control group; according to EPR, 0.02 ± 0.02 
mg/kg and 0.00, respectively). Thus, the hepatotoxic effect, too, did not display any signs of the 
organism’s adaptation to the effects of NiO-NPs. 
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At the same time, a histological investigation of the lung tissue by optical microscopy did not
reveal, even towards the end of the experiment, any cellular fibrotic nodules typical of experimental
pneumoconioses, or any thickening of interalveolar septae together with their diffuse fibrosis. On the
contrary, the septae became thinner or were even destroyed (emphysema), while the reticulin framework
was no coarser than in the control rats (Figure 6).
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Besides the above-considered functional indices, all internal organs displayed appreciable, even if
moderate, pathological changes in the histological structure confirmed by optical microscopy-based
morphometric assessment (Tables 7 and 8). The fact that there was no increase in the proportion
of akaryotic hepatocytes after the 3-month exposure is quite consistent with the observation that
in this period the retention of nickel in the liver was still negligibly low (according to AES data,
0.10 ± 0.05 against 0.08 ± 0.03 mg/kg in the control group; according to EPR, 0.02 ± 0.02 mg/kg and 0.00,
respectively). Thus, the hepatotoxic effect, too, did not display any signs of the organism’s adaptation
to the effects of NiO-NPs.
Table 7. Morphometric indices for th tate of rat’s liv r and spl en after inhalation exposure to NiO-NPs
at a 0.23 ± 0.01 mg/m3 concentration for 3, 6, or 10 months; mean results for at least 3 rats in exposed and
sham-exposed groups of each term, 10 serial microscopic section per an organ in a rat (x ± s.e.).
Indices
Duration of Exposure
3 Months 6 Months 10 Months
Sham NiO-NP Sham NiO-NP Sham NiO-NP
Count per 100 Liver Cells
Akaryotic
hepatocytes 15.7 ± 0.7 17.0 ± 0.7 18.1 ± 0.4 41.8 ± 1.1 * 24.0 ± 0.8 48.5 ± 1.1 *
Binucleated
hepatocytes 3.3 ± 0.3 4.9 ± 0.4 * 3.9 ± 0.2 3.1 ± 0.3 * 2.2 ± 0.2 3.7 ± 0.3 *
Kupffer cells 15.2 ± 0.4 16.8 ± 0.4 * 16.5 ± 0.3 18.7 ± 0.4 * 16.8 ± 0.5 19.5 ± 0.4 *
Spleen Slide Planimetry
Red pulp to white
pulp ratio 3.8 ± 0.6 3.3 ± 0.5 2.0 ± 0.2 2.2 ± 0.3 2.1 ± 0.3 1.9 ± 0.34
Diameter of the
follicle, mcm 12.9 ± 0.4 14.0 ± 0.3 13.2 ± 0.4 15.0 ± 0.5 * 13.0 ± 0.4 14.6 ± 0.5 *
Note: * statistically significant difference from the control group; p < 0.05 by a Student’s t-test with Bonferroni correction).
The reduced planimetric ratio of red pulp to white pulp in the spleen usually observed by us in
subchronic intraperitoneal experiments with nanoparticles [1] was found in this inhalation experiment
only by the first and last terms of investigation, and this ratio decrease was not statistically significant.
However, the response of the white pulp is evidenced by an increase in the average diameter of
lymphoid follicles observed in all periods of the experiment. Assumingly, it was a reactive follicular
hyperplasia associated not as much with the retention of nanoparticles in this organ as with the
probability of an allergic syndrome mentioned above (in the discussion of the data of Table 3).
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Table 8. Morphometric indices for the state of rat kidneys after inhalation exposure to NiO-NPs at a
0.23 ± 0.01 mg/m3 concentration for 3, 6, or 10 months; mean results for at least 3 rats in exposed and
sham-exposed groups of each term, 10 serial microscopic kidneys in a rat (x ± s.e.).
Indices
Duration of Exposure
3 Months 6 Months 10 Months
Sham NiO-NP Sham NiO-NP Sham NiO-NP
Brush border loss
(% lengthwise) 6.7 ± 1.8 15.7 ± 4.0 * 7.9 ± 3.5 17.2 ± 5.1 4.5 ± 2.5 6.2 ± 2.6
Epithelial desquamation
(% lengthwise) 1.3 ± 1.1 2.1 ± 1.2 1.1 ± 0.6 1.6 ± 0.8 1.9 ± 0.8 14.1 ± 4.3 *
Glomerular diameter. mcm 35.6 ± 0.7 36.4 ± 0.9 36.6 ± 0.7 37.3 ± 0.8 42.1 ± 0.8 36.0 ± 1.2 *
Note: * statistically significant difference from the control group; p < 0.05 by a Student’s t-test with Bonferroni correction).
For kidneys, as is common [1], the most typical adverse effect of NiO-NP toxicity was damage
to the tubular epithelium (Figure 7 and Table 8). The most obvious signs of such damage are brush
border loss in proximal convoluted tubules and full epithelial desquamation. However, although the
first of these effects was observed in all terms of the long-term inhalation exposure, it was statistically
significant only in the 3-month term. The second of the named effects was statistically significant only
in the 10-month term. For this term we only obtained a statistically significant difference in the average
diameter of the glomeruli between the exposed and sham-exposed groups. It is easy to see, though,
that this indicator in the exposed group was actually the same as in the previous periods, while in the
control group it increased unexpectedly. We therefore abstain from its toxicological interpretation.
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Figure 7. (a) Kidney of a control rat (proximal convoluted tubules with an intact brush border).
(b) Kidney of a rat exposed to NiO-NP inhalation during 10 months (marked degenerative and
necrobiotic changes in tubular epithelial cells up to their disappearance; partial destruction of the brush
border). Periodic acid–Schiff (PAS) stain; magnification: 400×.
The cytological changes in tissue imprints (Table 9) were generally of the same character as in the
pilot experiment (Table 3). At the same time, it is interesting that for some important indices of this kind
(for example, the percentage of eosinophils in the liver and spleen imprints), we can see an attenuation
of shifts caused by exposure as the duration of exposure increases, although in some cases (in particular,
the percentage of degeneratively changed cells in liver and kidney imprints), such attenuation was not
observed from the above morphometric characteristics of the histological preparations.
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Table 9. Some cytological characteristics of different organ imprints in rats sacrificed on the next day
after the last 4 h inhalation exposure to NiO-NPs at a 0.23 ± 0.01 mg/m3 concentration; percentage of
total cell count (x ± s.e.).
Organs and Cells In Sham-Exposed Rats (Control) In NiO-HP-Exposed Rats
3 Months 6 Months 10 Months 3 Months 6 Months 10 Months
Lungs
Alveolar
macrophages 4.60 ± 0.51 5.43 ± 0.57 4.60 ± 0.51 4.00 ± 0.38 10.29 ± 1.91 * 15.40 ± 0.75 *
Degeneratively
changed alveolar
macrophages
2.80 ± 1.32 2.29 ± 0.46 3.40 ± 0.81 26.60 ± 3.79 * 28.43 ± 1.84 * 34.00 ± 1.38 *
Neutrophils 20.00 ± 0.55 7.86 ± 0.50 4.40 ± 0.51 14.40 ± 2.46 * 3.14 ± 0.46 * 2.40 ± 0.24 *
Eosinophils 4.00 ± 0.66 2.00 ± 0.20 0.80 ± 0.20 4.20 ± 0.86 4.00 ± 0.44 * 0.40 ± 0.24
Liver
Degeneratively
changed hepatocytes 8.75 ± 0.84 3.29 ± 0.42 5.33 ± 0.42 21.86 ± 0.99 * 11.43 ± 0.87 * 8.17 ± 0.48 *
Neutrophils 7.20 ± 0.66 3.71 ± 0.68 5.83 ± 0.40 11.57 ± 0.97 * 8.14 ± 0.51 * 11.17 ± 0.95 *
Eosinophils 3.50 ± 0.40 0.71 ± 0.18 3.50 ± 0.67 7.29 ± 0.68 * 4.29 ± 0.61 * 3.00 ± 0.37
Kupffer cells 3.00 ± 0.68 1.29 ± 0.18 3.17 ± 0.60 5.43 ± 0.48 * 4.14 ± 0.91 * 4.67 ± 0.49
Kidneys
Cells of proximal
tubules 67.75 ± 0.85 67.86 ± 2.01 71.50 ± 0.85 51.00 ± 1.60 * 61.14 ± 1.44 * 57.71 ± 1.38 *
Degenerative cells of
proximal tubules 11.33 ± 0.58 5.29 ± 0.29 5.50 ± 0.45 22.71 ± 1.64 * 12.00 ± 0.82 * 13.00 ± 0.76 *
Cells of distal tubules 7.67 ± 0.85 10.00 ± 0.93 8.83 ± 0.76 10.00 ± 0.72 5.29 ± 0.61* 6.43 ± 0.48 *
Degenerative cells of
distal tubules 5.67 ± 0.65 4.71 ± 0.42 4.33 ± 0.22 8.43 ± 0.65 * 9.43 ± 0.65 * 9.43 ± 0.53 *
Spleen
Mature lymphocytes,
prolymphocytes 85.60 ± 2.29 90.00 ± 0.69 90.50 ± 0.29 72.57 ± 1.73 * 82.43 ± 1.49 * 79.00 ± 1.95 *
Lymphoblasts 0.80 ± 0.20 1.29 ± 0.18 1.17 ± 0.18 1.29 ± 0.29 0.86 ± 0.14 0.71 ± 0.18 *
Plasmocytes 1.40 ± 0.24 2.57 ± 0.72 2.33 ± 0.85 3.00 ± 0.53 * 3.57 ± 0.95 5.00 ± 0.79 *
Macrophages 2.40 ± 0.24 1.43 ± 0.30 1.17 ± 0.18 3.14 ± 0.34 2.14 ± 0.40 2.71 ± 0.42 *
Neutrophils 2.40 ± 0.51 2.57 ± 0.48 2.67 ± 0.50 4.43 ± 0.37 * 5.71 ± 0.47 * 7.00 ± 0.53 *
Eosinophils 4.60 ± 0.68 2.57 ± 0.43 2.67 ± 0.53 13.71 ± 0.97 * 4.71 ± 0.52 * 4.86 ± 0.74 *
Note: * statistically significant difference from the control (sham exposed) group ((p < 0.05 by a Student’s t-test).
2.3. Genotoxic Effect
The most important effect of toxic exposure to NiO-NPs that we found in all three periods of
inhalation exposure is a statistically significant increase (compared with the control values) in the
genomic DNA fragmentation coefficient (Cfr) in circulating nucleated blood cells (Table 6, the lowest
line). Previously we discovered this effect, along with a similar increase in Cfr, in cells of marrow
bone, the liver, and other organs, for the subchronic action of all metal-oxide nanoparticles that we
studied [1]. It can be regarded as a reliable quantitative indicator of genotoxicity inherent in all of
them in vivo. It is to be specially noted that, whereas in the sham-exposed group of this experiment
the value of Cfr remained constant throughout the entire period of observation, in the exposed group it
tended to increase as the duration of the inhalation exposure increased (the difference between the
first two periods being statistically significant). Thus, with regard to the genotoxic effect, no tendency
towards adaption of the organism to the adverse action of NiO-NPs is observable; on the contrary, this
effect is gradually increasing.
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Another piece of evidence supporting the association of the genotoxic effect with nickel-oxide
exposure is its attenuation by the background oral administration of a bioprotective complex (BPC),
which we tested for the first three months of the experiment. Whereas for rats exposed to nanoparticles
only, Cfr in this period was equal to 0.4480 ± 0.0017, for a similar exposure against the background
administration of the BPC, it was 0.4264 ± 0.0008 (p < 0.05). The administration of the BPC alone to
sham-exposed rats did not affect the control value significantly in any way.
3. Materials and Methods
For modeling chronic intoxication development under low-level but long-term inhalation
exposures to NiO nanoparticles, the experiments were carried out on outbred white female rats
from our own breeding colony with an initial body weight of 150–220 g, with a minimum of 12 animals
in exposed and control groups. Rats were housed in conventional conditions, breathed unfiltered air,
and were fed standard balanced food. The experiments were planned and implemented in accordance
with the “International guiding principles for biomedical research involving animals” developed by
the Council for International Organizations of Medical Sciences (1985) and were approved by the
Ethics Committee of the Ekaterinburg Medical Research Center Medical for Prophylaxis and Health
Protection in Industrial Workers.
Airborne NiO-NPs were obtained by sparking from 99.99% pure nickel rods using the Palas
DNP-3000 generator and fed into a nose-only exposure tower (CH Technologies, Westwood, NJ, USA)
for 60 rats placed into individual restrainers (Figure 8). A device of the same design obtained from the
same supplier was used for a sham exposure of control rats.
Particles collected on a polycarbonate filter and inspected under a scanning electron microscope
(SEM) had a spherical shape and either were singlets or formed small aggregates. The latter, if compact,
were measured as one particle. Even so, the particle size distribution (Figure 9) proved fairly clean-cut
and restricted to the nanometric range with a mean (± s.d.) diameter of 23 ± 5 nm. The chemical
identity of the NPs sampled on the filters was confirmed by Raman spectroscopy to be NiO.Int. J. Mol. Sci. 2018, 19, x 8 of 25 
 
 
Figure 8. (a) The nose-only inhalation device (photographed without door wings of the draught 
cupboard) and, in the background, a similar tower for the sham exposure of the control group; (b) 
restrainers with rats attached to the exposure tower. 
 
Figure 9. Particle or particle aggregate size distribution function obtained by statistical processing of 
250 (N0) measured SEM NPs images of particles accumulated on a polycarbonate filter from the 
exposed rats’ breathing zone. 
We studied NiO-NPs accumulated on the microporous PSI filter (Performance Systematix, Inc. 
– USA) from the air exhausted from the exposure tower for testing particle dissolution in water, in 
normal saline, in cell-free BALF (broncho-alveolar lavage fluid) supernatant, or in sterile bovine 
blood serum. The NiO content was measured on frozen filters by the electron paramagnetic 
resonance spectroscopy (EPR) method using the Bruker EMXplus EPR Spectrometer (USA) with an 
operating microwave frequency of 9–10 Hz at a temperature of ~177 К. The first-order derivative of 
the absorption spectrum was recorded. The integrated intensity (the area under the absorption 
signal), which is proportional to the mass of NiO in the sample, was determined by double 
integration. To check how this mass reduced with exposure time in the fluid, the filter was 
extracted at preset intervals for EPR measurement and then put back into the vessel with the fluid 
being studied.  
Rats were exposed or sham-exposed for 4 h a day, 5 times a week, for 3, 6, or 10 months. Along 
with each single exposure, a sample of airborne nanoparticles was collected on an acetyl cellulose 
fine fiber filter attached to the inhalation device instead of a rat’s nose, while the volume velocity of 
air drawn through the filter was being monitored. The mass of Ni retained on it was determined 
Figure 8. (a) The nose-only inhalation device (photographed without door wings of the draught
cupboard) and, in the background, a similar tower for the sham exposure of the control group;
(b) restrainers with rats attached to the exposure tower.
We studied NiO-NPs accumulated on the microporous PSI filter (Performance Systematix,
Inc.—Grand Rapids, MI, USA) from the air exhausted from the exposure tower for testing particle
dissolution in water, in normal saline, in cell-free BALF (broncho-alveolar lavage fluid) supernatant,
or in sterile bovine blood serum. The NiO content was measured on frozen filters by the electron
paramagnetic resonance spectroscopy (EPR) method using the Bruker EMXplus EPR Spectrometer
(USA) with an operating microwave frequency of 9–10 Hz at a temperature of ~177 K. The first-order
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derivative of the absorption spectrum was recorded. The integrated intensity (the area under the
absorption signal), which is proportional to the mass of NiO in the sample, was determined by double
integration. To check how this mass reduced with exposure time in the fluid, the filter was extracted at
preset intervals for EPR measurement and then put back into the vessel with the fluid being studied.
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Figure 9. Particle or particle aggregate size distribution function obtained by statistical processing
of 250 (N0) measured SEM NPs images of particles accumulated on a polycarbonate filter from the
exposed rats’ breathing zone.
Rats were exposed or sham-exposed for 4 h a day, 5 times a week, for 3, 6, or 10 months. Along
with each single exposure, sample of airborne nanoparticles was collected n an acetyl cellulose fine
fiber filter attached to the inhalation d vice instead of a rat’s nose, while the volume velocity of air
drawn through the filter was being mo itored. The m ss of Ni retained o it was determined with an
at mic absorption spectrometer ContrAA 700 (Analytic Jena A, Jena, Germany) and translated into the
mass of NiO and then into its air concentration as mg/m3.
Twenty-four hours after the final exposure in each of these periods, we performed (a) a
bronch -alveolar lavage to obtain a flui (BALF) for cytological and biochemical characterization and
(b) the following toxicometric tests:
1. weighing of the body;
2. estimation of the central nervous system’s ability to induce temporal summation of sub-threshold
impulses—a variant of withdrawal reflex and its facilitation by repeated electrical stimulations in
an intact, conscious rat;
3. recording of the number of head-dips into the holes of a hole-board (which is a simple but
informative index of the exploratory activity frequently used for studying behavioral effects of
toxicants and drugs) as well as of the number of squares crossed during the same time interval—as
a measure of motion activity;
4. collection of daily urine for analysis of its output (diuresis), specific gravity (density), protein,
total coproporphyrin, δ-aminolevulinic acid (δ-ALA), urea, uric acid, creatinine, and Ni content;
5. sampling of capillary blood from a notch on the tail for examining the hemogram and hemoglobin
content and for cytochemical determination of succinate dehydrogenase (SDH) activity in
lymphocytes (by the reduction of nitrotetrazolium violet to formazan, the number of granules of
which in a cell was counted under immersion microscopy).
The rats were then sacrificed by semi-decapitation, and blood was collected by exsanguination.
The liver, spleen, kidneys, and brain were weighed. The biochemical indices determined from the blood
included reduced glutathione (GSH), total serum protein, albumin, globulin, bilirubin, ceruloplasmin,
malondialdehyde (MDA), alkaline phosphatase, alanine- and asparate-transaminases (ALT, AST),
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catalase, gamma glutamyl transferase, SH-groups, urea, uric acid, creatinine, thyrotropic hormone of
hypophysis, thyroxin, and triiodothyronine.
All the routine clinical laboratory tests on blood and urine were performed using well-known
techniques described in many manuals (for instance, [42]).
The total nickel content of the liver, spleen, kidneys, and brain was determined by an atomic
emission spectrometer with inductively coupled plasma, iCAP-6500 Duo (Thermo Scientific, Waltham,
MA, USA). Samples of freeze-dried homogenized tissue were subjected to acid digestion with the
help of a MARS 5 microwave accelerated reaction system. Due to the paramagnetic properties of
nickel, the Ni2+ content of the same tissues was also studied using an electron paramagnetic resonance
spectrometer, EMX Plus Bruker (Bruker, Germany). This method enabled us to measure the metal
content in the chemical form of NiO (and, thus, as particulate Ni).
Liver, spleen, kidney, and brain tissue sections were prepared from 4 rats in each treated and
control group for histological examination by hematoxilin-eosine staining and, where necessary,
Periodic acid–Schiff (PAS), Nissl, or Perl’s stain. We used the Avtandilov’s planimetric ocular grid for
morphometric characterization of the spleen. Liver and kidneys were characterized morphometrically
using the programmed image-recognition system CellSens (Olympus, Ekaterinburg, Russia).
In addition, the pulmonary and brain accumulation of NPs and the ultrastructure of respective
tissues were visualized by means of transmission electron microscopy (TEM). To this end, pieces of
an organ were fixed in 2% paraformaldehyde and 2.5% glutaraldehyde in a cacodylate buffer with
5% sucrose at pH 7.3, post-fixed in 1% osmium tetroxide, contrasted with uranyl acetate en bloc,
and embedded in epoxy resin (Spurr). This sample preparation procedure was carried out in a
microwave tissue processor, HISTOS REM (Milestone, Milan, Italy). Semi-thin (900 nm thick) sections
of epoxy blocks were stained in toluidine blue with the addition of 1% borax and examined under the
optical microscope for choosing a site for TEM. The 60 nm ultrathin sections of this site obtained with the
help an ultramicrotome (Power Tome, «RMC», Tucson, AZ, USA) were contrasted with uranyl acetate
and lead citrate. Grid-mounted sections were investigated in an electron microscope, AURIGA («Carl
Zeiss; MT», Oberkochen, Germany) in the STEM mode in the range of magnifications 1200–200000.
3.1. Testing of Genotoxicity (the Random Amplification of Polymorphic DNA (RAPD) Test.)
Having assessed the adverse effects of subchronic intoxication caused in rats by many metal and
metal oxide nanoparticle species, we have proved that virtually all of them induce an increase in
genomic DNA fragmentation in cells of different tissues, always including circulating nucleated cells
of blood [1]. Therefore, the measuring of such fragmentation, albeit in these cells only, may serve as a
relatively simple but sufficiently informative index (indeed a kind of mirror) of in vivo nanoparticle
genotoxicity on the organism level.
The blood samples were collected in special vessels cooled to −80 ◦C. These were then promptly
delivered in cryocontainers to a specialized genetic laboratory.
To isolate DNA from the cells, we used a GenElute (Sigma) set of reagents in accordance
with the manufacturer’s guidelines for use. The DNA content of the samples was determined
spectrophotometrically (Ultraspec 1100 pro, Amersham Biosciences, Ltd., Amersham, UK), and they
were then frozen and stored at −84 ◦C in a kelvinator (Sanyo Electric Co., Ltd., Moriguchi, Japan)
until the beginning of the implementation of the RAPD (random amplified polymorphic DNA) test
performed as in many previous experiments of ours (e.g., [27]). This technique allows one to define
quantitatively the degree of DNA fragmentation as an estimate of a harmful agent’s genotoxicity and to
reveal the respective attenuative effect of bioprotectors studied. The method is based on the following
fact: unlike a fragmented DNA, which forms the so-called comet tail in the agarose gel electrophoresis,
a non-fragmented DNA displays a very low degree of migration and virtually stays in the same place
(comet head). The degree of DNA migration is directly related to the degree of DNA fragmentation.
DNA amplification was carried out using specific primers and tritiated nucleotides.
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In contrast with the traditional comet assay, which is based on subjective visual estimation of
the degree of damage to DNA of cells, the RAPD test allows for a quantitative determination of the
degree of DNA fragmentation. In our experiment, the separation of DNA was done by the standard
agarose gel-electrophoresis procedure. The polymerase chain reaction (PCR) was carried out using
specific primers complementary to the Alu sequences and nucleotides (dCTP, dATP, and methyl-dTTP)
labeled with tritium. The amplificate obtained was separated by horizontal agarose-gel electrophoresis
in the TAE-buffer at 100 V for 15 min. After the end of electrophoresis, the gel plates were divided
into tracks, each of which was cut into 5-mm-long sections. The resulting fragments of the gel were
placed into bottles containing 3.0 mL of absolute isopropanol. The bottles were then heated at 80 ◦C
for 2 h. Following extraction of the labeled amplified fragments from the gel, an ordinary toluene
scintillator (6.0 mL) was added to the bottles. The results were recorded with a Beta-2 automatic liquid
scintillation counter.
To characterize the degree of damage to DNA, we used the “coefficient of fragmentation” (Cfr)
i.e., the ratio of total radioactivity of all tail fractions to that of the head.
3.2. Choice of Bioprotectors
Based on the theoretical premises [22,24] and previous successful experiences in attenuating
the toxicity of different metallic nanoparticles, including Ag-NPs [43], CuO-NPs [44], and some
MeO-NPs combinations including NiO-NPs + Mn3O4-NPs [23], CuO-NPs + PbO-NPs + ZnO-NPs [26],
and Al2O3-NPs + TiO2-NP + SiO2-NPs [27]), we chose the following substances for inclusion into what
we call a “bioprotective complex” (BPC) to be administered per os along with the 3-month inhalation
exposure to NiO-NP:
1. Glutamate is an effective cell membrane stabilizer acting through the intensification of the ATP
synthesis under exposure to the damaging action of various cytotoxic particles (e.g., [22,45–47]).
At the same time, it is one of the precursors of glutathione, which is a powerful cell protector
against the oxidative stress. The latter is known to be a key mechanism underlying the cytotoxicity
and genotoxicity of virtually all metallic NPs [48]. Alongside these non-specific and almost
universal bio-protective effects, glutamate plays a major role in the transmission of excitatory
signals in the mammalian central nervous system and is thus involved in most aspects of normal
brain functioning. Given this role of glutamate, we assumed that its administration might
specifically increase resistance to nickel neurotoxicity.
2. The other two glutathione precursors were chosen—Glycine and cysteine (the latter in a highly
active and metabolically well available form of N-acetylcysteine)—given the generally important
role played by oxidative stress as a mechanism of metallic NP cytotoxicity and genotoxicity.
3. Other components of the organism’s anti-oxidant system (vitamins A, E, and C, rutin, and selenium)
were included as well.
4. ω-3 polyunsaturated fatty acids (PUFA), whose intracellular derivatives are eicosanoids, activate
DNA replication and thus play an important part in its repair, as was demonstrated by us earlier
under exposure to various genotoxic agents (e.g., [27,30])
5. Iodine supplement was chosen given the complex disturbances of the thyroid function caused by
different metallic intoxications.
6. Pectin enterosorbent was also chosen, as it is an agent that hinders both the primary intestinal
absorption of metal ions released by MeO-NPs transferred to the GIT from the airways via the
throat and the re-absorption of toxic metals excreted into the intestines with bile.
The doses and methods of administration of these bio-protectors were as follows: apple pectin:
1 g/kg body weight (added to the fodder); sodium glutamate: 160 mg per rat (as a 1.5% drink instead
of water); glycine: 3 mg per rat (added to the fodder); N-acetylcysteine: 9.3 mg per rat (added to the
fodder); vitamin C: 5.65 mg per rat (added to the fodder); rutin: 1.5 mg per rat (added to the fodder);
vitamin A: 0.3 mg per rat (added to the fodder); vitamin E: 0.9 mg per rat (added to the fodder);
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selenium: 1.5 mcg per rat (added to the fodder); potassium iodide: 1.5 mcg per rat (added to the
fodder); a commercial fish oil rich in vitamin A and omega-3-rich PUFA: 1 drop per rat (per gavage).
We gave glutamate to rats as a 1.5% solution ad libitum instead of the drinking water. The “Amber
Dew” (by Ecco-Plus Ltd., Zhukovskiy, Russia), a fish oil preparation rich in PUFA mainly of the ω-3
group (24%), was administered through gavage at a dose of 1 mL per rat. The apple pectin enterosorbent
(by Promavtomatika Ltd., Belgorod, Russia) was added to the rats’ fodder in a quantity corresponding to
a dose ca. 1000 mg/kg body mass. The amino acids and vitamins available as tablets were crushed and
added to another portion of the fodder in quantities corresponding to the recommended daily intake of
these micronutrients by rats (where such recommendations were known only for humans, a recalculation
to the rat’s nutritional requirement was made based on the species’ standard metabolism ratio).
Presuming that the standard balanced fodder meets the normal nutritional requirements of rat,
we suggested that additional intake of the above-listed bioactive substances would meet the increased
needs due to the molecular mechanisms of NiO-NP toxicity. Nevertheless, it had to be checked whether
or not such presumed overloading with bioactive substances would evoke any unfavorable effects.
That is why in our experiments one group of rats was administered the same BPC but was not exposed
to any toxicant.
The statistical significance of the differences between the group arithmetic mean values was
estimated using a Student’s t test with Bonferroni correction for multiple comparisons.
4. Conclusions
In general, the response of the rat organism to the impact of inhaled nickel oxide nanoparticles
corresponds to the patterns that are characteristic of many other previously studied metal and
metal-oxide nanoparticle species. The following should be specially noted: (a) typical changes in
the cytological and some biochemical characteristics of BALF in response to inhalation of NiO-NPs;
(b) various manifestations of systemic toxicity with especially marked damage to the liver and kidneys;
(c) some transfer of nanoparticles from the nasal mucous membrane along the olfactory tract, causing
damage to the corresponding structures of the brain; (d) a paradoxically mild pulmonary pathology of
the pneumoconiotic type, which can be explained by a low chronic retention of nanoparticles in the
lungs due to their solubilization in biological milieus; (e) the genotoxic effect on the organism level
reliably identified even under low levels of chronic exposure at which the above manifestations of
systemic toxicity are rather mild.
However, along with such a generalized toxicological characteristic of metal-oxide nanoparticles,
their action quite often involves an important role of harmful effects representative of the toxicity of
some specific chemical element [1]. In the case of NiO-NPs, we consider as such the element-specific
changes in the red blood indices pointing to the phase-related stimulation of erythropoiesis. We are
the first to come across an alternating character of an organism’s response to chronic exposure to
nanoparticles and the manifestations of the apparent adaptation to such exposure, judging not only by
the hematological but also by other (though far from all) effects.
From the standpoint of preventive and, in particular, regulatory toxicology, we think that the most
important conclusion from these studies is that NiO-NP aerosol possesses doubtless, albeit moderate,
toxicity even in low concentrations, which in Ni terms either correspond to, or are lower by almost an
order of magnitude than, the standards widely adopted for nickel and its compounds in non-nano
form. In order to validate such a standard for nickel-oxide nanoparticles, we are currently conducting
a similar chronic inhalation experiment involving an even lower concentration of NiO-NPs. However,
it is clear that maintaining such low levels of exposure in actual industrial occupational settings could
be a major challenge. This makes it especially important to find ways to enhance the resistance of the
organism to nano-impacts by means of safe bioprotectors [24]. It is therefore important that in the
experiments presented in this paper, we have proved the possibility of such bioprotection (specifically,
the significant attenuation of the genotoxic effect of NiO-NPs).
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